Press Release
Bezuclastinib combination is first treatment ever to demonstrate statistically significant advantage against active comparator in GIST patients; median PFS of 16.5 months versus 9.2…
CAZENOVIA, N.Y., April 30, 2026 (GLOBE NEWSWIRE) — Farmstead 1868 is proud to announce that…
MILTON, Del., April 30, 2026 (GLOBE NEWSWIRE) — Delaware’s Dogfish Head Craft Brewery and CBS’s…
Dublin, April 30, 2026 (GLOBE NEWSWIRE) — The “Sterile Injectables CDMO Market Report 2026” has…
Acquisition marks Svitla’s entry into the Australian market and strengthens capabilities in low-code, Microsoft technologies,…
Dublin, April 30, 2026 (GLOBE NEWSWIRE) — The “Tylosin Market Report 2026” has been added…
MONTREAL, April 30, 2026 (GLOBE NEWSWIRE) — Cantech®, a leader in the pressure-sensitive tape industry…